CORPORATE ANNOUNCEMENT – 16th March 2020

URGENT – COVID-19

Farmhispania Group (FHG) has been following closely the development of the Coronavirus. FHG is following the legislations and recommendations of the World’s leading Health Organisations and National/Autonomous authorities.

The Spanish Government has identified and assigned as essential the pharmaceutical industry. FHG is committed to maximise protection of its employees whilst at the same time supporting the health industry by assuring supply of our Active Pharmaceutical Ingredients with the goal of affording minimal impact on the availability of critical medicines.

FHG has implemented, amongst others, the following measures to support this goal.

✓ As of end of February a crisis committee was created.

✓ Frequent monitoring of supply chain and advancing wherever possible deliveries to assure business continuity.

✓ Posting of COVID-19 information and good hygiene practices.

✓ Installation of additional hand sanitisers.

✓ Travel restrictions for employees including between FHG sites.

✓ Postponement of external meetings and audits.

✓ For critical site visits/regulatory inspections, a protocol has been established.

✓ Use of video conferencing to support internal and external communications.

✓ Remote working for non-site critical personnel.

FHG will continue to closely monitor the situation and update its measures accordingly. We appreciate your full support and understanding during this challenging period.

Finally, FHG wishes to sincerely thank all its employees for their commitment and support.

Farmhispania Group Management

Welcome to FARMHISPANIA GROUP

EXEMPLARY LONG TRACK RECORD WITH REGULATORY AUTHORITIES

5 R&D LABORATORIES WITH MORE THAN 60 SCIENTISTS

LEADING EUROPEAN CDMO IN HPAPI TECHNOLOGIES

HIGH POTENCY FERMENTATION

STATE-OF-THE-ART MULTIPURPOSE CAPABILITIES

MORE THAN 40 YEARS OF EXPERIENCE MANUFACTURING YOUR API’S

TWO GMP FDA INSPECTED MANUFACTURING SITES IN SPAIN